{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:49:36Z","timestamp":1791532176257,"version":"4.3.4"},"reference-count":199,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"DOI":"10.1007\/s11274-026-05249-6","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:25:47Z","timestamp":1788413147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From metabolites to membrane vesicles: Unifying gut microbial signals in obesity, t2dm, and MASLD"],"prefix":"10.1007","volume":"42","author":[{"given":"Barathan","family":"Muttiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopinath","family":"Venkatraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puteri Shafinaz","family":"Abdul-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"5249_CR1","doi-asserted-by":"crossref","unstructured":"Abdulaal R, Tlaiss Y, Jammal F, Moussbah TH, Tarchichi A, Hteit A, Tlais M, Nassif D (2025) The role of microbiome dysbiosis in cardiovascular disease: mechanisms and therapeutic implications. Glob Cardiol Sci Pract","DOI":"10.21542\/gcsp.2025.3"},{"key":"5249_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40659-023-00436-3","volume":"56","author":"J Abrigo","year":"2023","unstructured":"Abrigo J, Olgu\u00edn H, Tacchi F, Orozco-Aguilar J, Valero-Breton M, Soto J, Castro-Sep\u00falveda M, Elorza AA, Simon F, Cabello-Verrugio C (2023) Cholic and deoxycholic acids induce mitochondrial dysfunction, impaired biogenesis and autophagic flux in skeletal muscle cells. Biol Res 56:30","journal-title":"Biol Res"},{"key":"5249_CR4","doi-asserted-by":"publisher","first-page":"100375","DOI":"10.1016\/j.metop.2025.100375","volume":"27","author":"SK Ahmed","year":"2025","unstructured":"Ahmed SK, Mohammed RA (2025) Obesity: Prevalence, causes, consequences, management, preventive strategies and future research directions. Metabol Open 27:100375","journal-title":"Metabol Open"},{"key":"5249_CR5","first-page":"350","volume":"29","author":"M Akhtar","year":"2021","unstructured":"Akhtar M, Chen Y, Ma Z, Zhang X, Shi D, Khan JA, Liu H (2021) Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation. Anim Nutr 29:350\u2013360","journal-title":"Anim Nutr"},{"key":"5249_CR6","doi-asserted-by":"publisher","first-page":"e70080","DOI":"10.1096\/fba.2025-00218","volume":"8","author":"M Al Qassab","year":"2026","unstructured":"Al Qassab M, Chaarani N, Hamou A, Harb R, Jradi A, Zeineddine M, Ghadieh HE, Khattar ZA, Azar S, Kanaan A, Harb F (2026) The Gut Microbiota-Insulin Resistance Axis: Mechanisms, Clinical Implications, and Therapeutic Potential. FASEB Bioadv 8:e70080","journal-title":"FASEB Bioadv"},{"key":"5249_CR7","doi-asserted-by":"publisher","first-page":"1108088","DOI":"10.3389\/fnut.2023.1108088","volume":"10","author":"MA Aldubayan","year":"2023","unstructured":"Aldubayan MA, Mao X, Laursen MF, Pigsborg K, Christensen LH, Roager HM, Nielsen DS, Hjorth MF, Magkos F (2023) Supplementation with inulin-type fructans affects gut microbiota and attenuates some of the cardiometabolic benefits of a plant-based diet in individuals with overweight or obesity. Front Nutr 10:1108088","journal-title":"Front Nutr"},{"key":"5249_CR8","doi-asserted-by":"publisher","first-page":"837509","DOI":"10.3389\/fphar.2021.837509","volume":"12","author":"P Amiri","year":"2022","unstructured":"Amiri P, Hosseini SA, Ghaffari S, Tutunchi H, Ghaffari S, Mosharkesh E, Asghari S, Roshanravan N (2022) Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review. Front Pharmacol 12:837509","journal-title":"Front Pharmacol"},{"key":"5249_CR9","doi-asserted-by":"publisher","first-page":"103413","DOI":"10.1016\/j.mcn.2019.103413","volume":"101","author":"N Ammal Kaidery","year":"2019","unstructured":"Ammal Kaidery N, Ahuja M, Thomas B (2019) Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson\u2019s disease. Mol Cell Neurosci 101:103413","journal-title":"Mol Cell Neurosci"},{"key":"5249_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","volume":"26","author":"L An","year":"2022","unstructured":"An L, Wirth U, Koch D, Schirren M, Drefs M, Koliogiannis D, Nie\u00df H, Andrassy J, Guba M, Bazhin AV, Werner J, K\u00fchn F (2022) The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases. J Gastrointest Surg 26:671\u2013683","journal-title":"J Gastrointest Surg"},{"key":"5249_CR11","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1002\/fsn3.3465","volume":"11","author":"A Asif","year":"2023","unstructured":"Asif A, Afzaal M, Shahid H, Saeed F, Ahmed A, Shah YA, Ejaz A, Ghani S, Ateeq H, Khan MR (2023) Probing the functional and therapeutic properties of postbiotics in relation to their industrial application. Food Sci Nutr 11:4472\u20134484","journal-title":"Food Sci Nutr"},{"key":"5249_CR12","doi-asserted-by":"publisher","first-page":"15356","DOI":"10.1038\/s41598-025-98973-2","volume":"15","author":"V Aya","year":"2025","unstructured":"Aya V, Pardo-Rodriguez D, Vega LC, Cala MP, Ram\u00edrez JD (2025) Integrating metagenomics and metabolomics to study the gut microbiome and host relationships in sports across different energy systems. Sci Rep 15:15356","journal-title":"Sci Rep"},{"key":"5249_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13099-025-00730-3","volume":"17","author":"YR Bah","year":"2025","unstructured":"Bah YR, Baba K, Mustafa DNAB, Watanabe S, Takeda AK, Yamashita T, Kasahara K (2025) Bacteroides- and Prevotella-enriched gut microbial clusters associate with metabolic risks. Gut Pathog 17:55","journal-title":"Gut Pathog"},{"key":"5249_CR14","doi-asserted-by":"publisher","first-page":"1637071","DOI":"10.3389\/fnut.2025.1637071","volume":"12","author":"W Bahitham","year":"2025","unstructured":"Bahitham W, Banoun Y, Aljahdali M, Almuaiqly G, Bahshwan SM, Aljahdali L, Sanai FM, Rosado AS, Sergi CM (2025) Trust your gut: exploring the connection between gut microbiome dysbiosis and the advancement of Metabolic Associated Steatosis Liver Disease (MASLD)\/Metabolic Associated Steatohepatitis (MASH): a systematic review of animal and human studies. Front Nutr 12:1637071","journal-title":"Front Nutr"},{"key":"5249_CR15","doi-asserted-by":"publisher","first-page":"e70078","DOI":"10.1002\/biof.70078","volume":"52","author":"S Baldi","year":"2026","unstructured":"Baldi S, Turrini M, Cei F, Menicatti M, Bartolucci G, Amedei A (2026) Bile Acids as Key Mediators of the Gut Microbiota-Immune Axis: Potential Biomarker and Therapeutic Perspectives. BioFactors 52:e70078","journal-title":"BioFactors"},{"key":"5249_CR16","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.3390\/foods10112528","volume":"10","author":"R Ballan","year":"2021","unstructured":"Ballan R, Saad SMI (2021) Characteristics of the Gut Microbiota and Potential Effects of Probiotic Supplements in Individuals with Type 2 Diabetes mellitus. Foods 10:2528","journal-title":"Foods"},{"key":"5249_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/07315724.2010.10719830","volume":"29","author":"MY Barakatun Nisak","year":"2010","unstructured":"Barakatun Nisak MY, Ruzita AT, Norimah AK, Gilbertson H, Nor Azmi K (2010) Improvement of dietary quality with the aid of a low glycemic index diet in Asian patients with type 2 diabetes mellitus. J Am Coll Nutr 29:161\u2013170","journal-title":"J Am Coll Nutr"},{"key":"5249_CR18","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.3390\/ijms25074024","volume":"25","author":"M Barathan","year":"2024","unstructured":"Barathan M, Ng SL, Lokanathan Y, Ng MH, Law JX (2024) The Profound Influence of Gut Microbiome and Extracellular Vesicles on Animal Health and Disease. Int J Mol Sci 25:4024","journal-title":"Int J Mol Sci"},{"key":"5249_CR19","doi-asserted-by":"publisher","first-page":"G845","DOI":"10.1152\/ajpgi.00346.2018","volume":"17","author":"SE Blutt","year":"2019","unstructured":"Blutt SE, Klein OD, Donowitz M, Shroyer N, Guha C, Estes MK (2019) Use of organoids to study regenerative responses to intestinal damage. Am J Physiol Gastrointest Liver Physiol 17:G845\u2013G852","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5249_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/cimb47060424","volume":"47","author":"S Borozan","year":"2025","unstructured":"Borozan S, Fernandez CJ, Samee A, Pappachan JM (2025) Gut-Adipose Tissue Axis and Metabolic Health. Curr Issues Mol Biol 47:424","journal-title":"Curr Issues Mol Biol"},{"key":"5249_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.biochi.2015.06.020","volume":"124","author":"NE Boutagy","year":"2016","unstructured":"Boutagy NE, McMillan RP, Frisard MI, Hulver MW (2016) Metabolic endotoxemia with obesity: Is it real and is it relevant? Biochimie 124:11\u201320","journal-title":"Biochimie"},{"key":"5249_CR22","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.3390\/cells11193091","volume":"11","author":"LRF Bresser","year":"2022","unstructured":"Bresser LRF, de Goffau MC, Levin E, Nieuwdorp M (2022) Gut Microbiota in Nutrition and Health with a Special Focus on Specific Bacterial Clusters. Cells 11:3091","journal-title":"Cells"},{"key":"5249_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/dom.14899","volume":"25","author":"M Camilleri","year":"2023","unstructured":"Camilleri M (2023) Is intestinal permeability increased in obesity? A review including the effects of dietary, pharmacological and surgical interventions on permeability and the microbiome. Diabetes Obes Metab 25:325\u2013330","journal-title":"Diabetes Obes Metab"},{"key":"5249_CR24","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3390\/ijms26052229","volume":"26","author":"TI Campos-Bayardo","year":"2025","unstructured":"Campos-Bayardo TI, Rom\u00e1n-Rojas D, Garc\u00eda-S\u00e1nchez A, Cardona-Mu\u00f1oz EG, S\u00e1nchez-Lozano DI, Totsuka-Sutto S, G\u00f3mez-Hermosillo LF, Casillas-Moreno J, Andrade-Sierra J, Pazar\u00edn-Villase\u00f1or L, Campos-P\u00e9rez W, Mart\u00ednez-L\u00f3pez E, Miranda-D\u00edaz AG (2025) The Role of TLRs in Obesity and Its Related Metabolic Disorders. Int J Mol Sci 26:2229","journal-title":"Int J Mol Sci"},{"key":"5249_CR25","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.3390\/ijms24031940","volume":"24","author":"M Canyelles","year":"2023","unstructured":"Canyelles M, Borr\u00e0s C, Rotllan N, Tondo M, Escol\u00e0-Gil JC, Blanco-Vaca F (2023) Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? Int J Mol Sci 24:1940","journal-title":"Int J Mol Sci"},{"key":"5249_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/metabo15040220","volume":"15","author":"E Caradonna","year":"2025","unstructured":"Caradonna E, Abate F, Schiano E, Paparella F, Ferrara F, Vanoli E, Difruscolo R, Goffredo VM, Amato B, Setacci C, Setacci F, Novellino E (2025) Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health. Metabolites 15:220","journal-title":"Metabolites"},{"key":"5249_CR27","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/ph18091321","volume":"18","author":"L Cerrito","year":"2025","unstructured":"Cerrito L, Galasso L, Iaccarino J, Pizzi A, Termite F, Esposto G, Borriello R, Ainora ME, Gasbarrini A, Zocco MA (2025) Present and Future Perspectives in the Treatment of Liver Fibrosis. Pharmaceuticals (Basel) 18:1321","journal-title":"Pharmaceuticals (Basel)"},{"key":"5249_CR28","doi-asserted-by":"publisher","first-page":"102539","DOI":"10.1016\/j.cbpa.2024.102539","volume":"83","author":"PV Chang","year":"2024","unstructured":"Chang PV (2024) Microbial metabolite-receptor interactions in the gut microbiome. Curr Opin Chem Biol 83:102539","journal-title":"Curr Opin Chem Biol"},{"key":"5249_CR29","doi-asserted-by":"publisher","first-page":"e000384","DOI":"10.1136\/bmjdrc-2016-000384","volume":"5","author":"WSS Chee","year":"2017","unstructured":"Chee WSS, Gilcharan Singh HK, Hamdy O, Mechanick JI, Lee VKM, Barua A, Mohd Ali SZ, Hussein Z (2017) Structured lifestyle intervention based on a trans-cultural diabetes-specific nutrition algorithm (tDNA) in individuals with type 2 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care 5:e000384","journal-title":"BMJ Open Diabetes Res Care"},{"key":"5249_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.20517\/evcna.2026.09","volume":"7","author":"J Chen","year":"2026","unstructured":"Chen J, Chen Q, Li B, Pan C, Grau R, Liu T, Li S, Wang Q, Wang Y, Yang Y, Cheng J, Jin Y, Yang G (2026a) Engineered bacterial extracellular vesicles as next-generation precision postbiotics: strategies, challenges and prospects. Extracell Vesicles Circ Nucleic Acids 7:714\u2013746","journal-title":"Extracell Vesicles Circ Nucleic Acids"},{"key":"5249_CR31","doi-asserted-by":"publisher","first-page":"e70657","DOI":"10.1111\/cns.70657","volume":"31","author":"J Chen","year":"2025","unstructured":"Chen J, Liu B, Yao X, Yang X, Sun J, Yi J, Xue F, Zhang J, Shen Y, Chen B, Sun H (2025a) AMPK\/SIRT1\/PGC-1\u03b1 Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy. CNS Neurosci Ther 31:e70657","journal-title":"CNS Neurosci Ther"},{"key":"5249_CR32","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1111\/dom.16446","volume":"27","author":"LL Chen","year":"2025","unstructured":"Chen LL, Tohit NM, Ludin AFM, Manaf ZA, Wong A, Kuan KL, Chien HW, Shahar S (2025b) Efficacy of diabetes-specific partial meal replacement on glycemic and weight control in type 2 diabetes: A randomized controlled trial. Diabetes Obes Metab 27:4167\u20134180","journal-title":"Diabetes Obes Metab"},{"key":"5249_CR33","doi-asserted-by":"publisher","first-page":"e006347","DOI":"10.1161\/JAHA.117.006347","volume":"6","author":"ML Chen","year":"2017","unstructured":"Chen ML, Zhu XH, Ran L, Lang HD, Yi L, Mi MT (2017) Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway. J Am Heart Assoc 6:e006347","journal-title":"J Am Heart Assoc"},{"key":"5249_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2026.103036","volume":"116","author":"N Chen","year":"2026","unstructured":"Chen N, Chan CK, Khan FU, Makhijani P, Valentino TR, Winer S, Luk CT, Winer DA (2026b) Gut microbiota-derived metabolites as immune modulators in aging and age-related chronic inflammatory diseases. Ageing Res Rev 116:103036","journal-title":"Ageing Res Rev"},{"key":"5249_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1856667","volume":"17","author":"Y Chen","year":"2026","unstructured":"Chen Y, Jin D, Han X, Liu X, Liu Y, Wang L (2026c) Gut microbiota in type 2 diabetes mellitus: mechanistic links between dysbiosis, insulin resistance, and chronic low-grade inflammation. Front Endocrinol (Lausanne) 17:1856667","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5249_CR36","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","volume":"3","author":"JY Chiang","year":"2013","unstructured":"Chiang JY (2013) Bile acid metabolism and signaling. Compr Physiol 3:1191\u20131212","journal-title":"Compr Physiol"},{"key":"5249_CR37","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM (2020) Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol 318:G554\u2013G573","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5249_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199715","volume":"26","author":"W Choi","year":"2025","unstructured":"Choi W, Woo GH, Kwon TH, Jeon JH (2025) Obesity-driven metabolic disorders: the interplay of inflammation and mitochondrial dysfunction. Int J Mol Sci 26:9715","journal-title":"Int J Mol Sci"},{"key":"5249_CR39","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska A, Matyjek M, Kwiatkowska K (2021) TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 78:1233\u20131261","journal-title":"Cell Mol Life Sci"},{"key":"5249_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/nu15122749","volume":"15","author":"VJ Clemente-Su\u00e1rez","year":"2023","unstructured":"Clemente-Su\u00e1rez VJ, Beltr\u00e1n-Velasco AI, Redondo-Fl\u00f3rez L, Mart\u00edn-Rodr\u00edguez A, Tornero-Aguilera JF (2023) Global impacts of western diet and its effects on metabolism and health: a narrative review. Nutrients 15:2749","journal-title":"Nutrients"},{"key":"5249_CR41","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/antiox12030658","volume":"12","author":"KA Cojocaru","year":"2023","unstructured":"Cojocaru KA, Luchian I, Goriuc A, Antoci LM, Ciobanu CG, Popescu R, Vlad CE, Blaj M, Foia LG (2023) Mitochondrial Dysfunction, Oxidative Stress, and Therapeutic Strategies in Diabetes, Obesity, and Cardiovascular Disease. Antioxid (Basel) 12:658","journal-title":"Antioxid (Basel)"},{"key":"5249_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/toxres\/tfaa065","volume":"9","author":"AR Conteh","year":"2020","unstructured":"Conteh AR, Huang R (2020) Targeting the gut microbiota by Asian and Western dietary constituents: a new avenue for diabetes. Toxicol Res 9:569\u2013577","journal-title":"Toxicol Res"},{"key":"5249_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110445","volume":"26","author":"IM Crasan","year":"2025","unstructured":"Crasan IM, Tanase M, Delia CE, Gradisteanu-Pircalabioru G, Cimpean A, Ionica E (2025) Metaflammation\u2019s role in systemic dysfunction in obesity: a comprehensive review. Int J Mol Sci 26:10445","journal-title":"Int J Mol Sci"},{"key":"5249_CR44","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/molecules31030490","volume":"31","author":"PV Czaj","year":"2026","unstructured":"Czaj PV, Szewczyk-Golec K, Nuszkiewicz J, Wo\u017aniak A (2026) Gut Dysbiosis and Microbiota-Derived Metabolites in Neurodegenerative Diseases: Molecular and Biochemical Mechanisms Along the Gut-Brain Axis. Molecules 31:490","journal-title":"Molecules"},{"key":"5249_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/biom16020226","volume":"16","author":"M Del Corn\u00f2","year":"2026","unstructured":"Del Corn\u00f2 M, Aureli A, Varano B, Conti L (2026) Endotoxins and metabolic endotoxemia in obesity and associated noncommunicable diseases: a focus on sex differences. Biomolecules 16:226","journal-title":"Biomolecules"},{"key":"5249_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110539","volume":"26","author":"LMT Dicks","year":"2025","unstructured":"Dicks LMT (2025) Key signals produced by gut microbiota associated with metabolic syndrome, cancer, cardiovascular diseases, and brain functions. Int J Mol Sci 26:10539","journal-title":"Int J Mol Sci"},{"key":"5249_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.915218","volume":"13","author":"HX Du","year":"2022","unstructured":"Du HX, Yue SY, Niu D, Liu C, Zhang LG, Chen J, Chen Y, Guan Y, Hua XL, Li C, Chen XG, Zhang L, Liang CZ (2022) Gut microflora modulates Th17\/Treg cell differentiation in experimental autoimmune prostatitis via the short-chain fatty acid propionate. Front Immunol 13:915218","journal-title":"Front Immunol"},{"key":"5249_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1618275","volume":"12","author":"A Dua","year":"2025","unstructured":"Dua A, Kumari R, Singh M, Kumar R, Pradeep S, Ojesina AI, Kumar R (2025) Metabolic dysfunction-associated steatotic liver disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes. Front Med (Lausanne) 12:1618275","journal-title":"Front Med (Lausanne)"},{"key":"5249_CR49","volume":"7","author":"J Dwiyanto","year":"2021","unstructured":"Dwiyanto J, Ayub Q, Lee SM, Foo SC, Chong CW, Rahman S (2021a) Geographical separation and ethnic origin influence the human gut microbial composition: a meta-analysis from a Malaysian perspective. Microb Genom 7:000619","journal-title":"Microb Genom"},{"key":"5249_CR50","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1038\/s41598-021-82311-3","volume":"11","author":"J Dwiyanto","year":"2021","unstructured":"Dwiyanto J, Hussain MH, Reidpath D, Ong KS, Qasim A, Lee SWH, Lee SM, Foo SC, Chong CW, Rahman S (2021b) Ethnicity influences the gut microbiota of individuals sharing a geographical location: a cross-sectional study from a middle-income country. Sci Rep 11:2618","journal-title":"Sci Rep"},{"key":"5249_CR51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1021\/cb500846u","volume":"10","author":"J Fan","year":"2015","unstructured":"Fan J, Krautkramer KA, Feldman JL, Denu JM (2015) Metabolic regulation of histone post-translational modifications. ACS Chem Biol 10:95\u2013108","journal-title":"ACS Chem Biol"},{"key":"5249_CR52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13104-026-07859-7","volume":"19","author":"M Farboud","year":"2026","unstructured":"Farboud M, Hessam S, Vahdat S, Tofighi S (2026) Predicting metabolic syndrome in Iranian adults using artificial neural networks: a comparative analysis with logistic regression based on demographic, lifestyle, and clinical indicators. BMC Res Notes 19:298","journal-title":"BMC Res Notes"},{"key":"5249_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1674477","volume":"16","author":"Z Feng","year":"2025","unstructured":"Feng Z, Tan Z, Lu D (2025) Mitochondrial bioenergetics dysfunction in T2DM: linking oxidative stress to insulin resistance. Front Endocrinol (Lausanne) 16:1674477","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5249_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman JS, Kumar S (2024) Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther 9:97","journal-title":"Signal Transduct Target Ther"},{"key":"5249_CR57","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/biomedicines14040752","volume":"14","author":"H Fuentes-Barr\u00eda","year":"2026","unstructured":"Fuentes-Barr\u00eda H, Aguilera-Egu\u00eda R, Flores-Fern\u00e1ndez C, Angarita-Davila L, Alarc\u00f3n-Rivera M (2026) Type 2 Diabetes Mellitus as a Multisystem Disease: From Insulin Resistance to Organ Crosstalk-A Narrative Review. Biomedicines 14:752","journal-title":"Biomedicines"},{"key":"5249_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26168081","volume":"26","author":"G Gallo","year":"2025","unstructured":"Gallo G, Nalli G, Baratta F, Desideri G, Savoia C (2025) Metabolic dysfunction-associated steatotic liver disease: a silent driver of cardiovascular risk and a new target for intervention. Int J Mol Sci 26:8081","journal-title":"Int J Mol Sci"},{"key":"5249_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658354","volume":"12","author":"N Gasaly","year":"2021","unstructured":"Gasaly N, de Vos P, Hermoso MA (2021) Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation. Front Immunol 12:658354","journal-title":"Front Immunol"},{"key":"5249_CR60","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.2147\/JIR.S468609","volume":"17","author":"M G\u0105ssowska-Dobrowolska","year":"2024","unstructured":"G\u0105ssowska-Dobrowolska M, Olech-Kocha\u0144czyk G, Culmsee C, Adamczyk A (2024) Novel Insights into Parkin-Mediated Mitochondrial Dysfunction and Mito-Inflammation in \u03b1-Synuclein Toxicity. The Role of the cGAS-STING Signalling Pathway. J Inflamm Res 17:4549\u20134574","journal-title":"J Inflamm Res"},{"key":"5249_CR62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s43856-025-00838-2","volume":"5","author":"C Ge","year":"2025","unstructured":"Ge C, Xiong J, Zhu R, Hong Z, He Y (2025) The global burden of high BMI among adolescents between 1990 and 2021. Commun Med (Lond) 5:125","journal-title":"Commun Med (Lond)"},{"key":"5249_CR63","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jcmgh.2021.02.007","volume":"11","author":"S Ghosh","year":"2021","unstructured":"Ghosh S, Whitley CS, Haribabu B, Jala VR (2021) Regulation of Intestinal Barrier Function by Microbial Metabolites. Cell Mol Gastroenterol Hepatol 11:1463\u20131482","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"5249_CR64","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s00253-024-13384-z","volume":"108","author":"D Go","year":"2024","unstructured":"Go D, Yeon GH, Park SJ, Lee Y, Koh HG, Koo H, Kim KH, Jin YS, Sung BH, Kim J (2024) Integration of metabolomics and other omics: from microbes to microbiome. Appl Microbiol Biotechnol 108:538","journal-title":"Appl Microbiol Biotechnol"},{"key":"5249_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.iliver.2025.100195","volume":"4","author":"C Gou","year":"2025","unstructured":"Gou C, Zhang W, Xu H, Zhang H, Ding R, Zhang X (2025) Pathogenesis of metabolic dysfunction-associated steatotic liver disease and donor liver damage. ILIVER 4:100195","journal-title":"ILIVER"},{"key":"5249_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.70662","volume":"2","author":"M Grocic","year":"2026","unstructured":"Grocic M, Nguyen M, Sanyal AJ (2026) Current Trends in the Epidemiology of Obesity and the Association Between Obesity and Metabolic Liver Disease (MASLD\/MASH). Diabetes Obes Metab Suppl 2:3\u201318","journal-title":"Diabetes Obes Metab Suppl"},{"key":"5249_CR67","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/metabo13060760","volume":"13","author":"L Guiducci","year":"2023","unstructured":"Guiducci L, Nicolini G, Forini F (2023) Dietary Patterns, Gut Microbiota Remodeling, and Cardiometabolic Disease. Metabolites 13:760","journal-title":"Metabolites"},{"key":"5249_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1638240","volume":"16","author":"S Guo","year":"2025","unstructured":"Guo S, Zhao J, Zhu R, Fan Z, Liu S, Wu W (2025) Epigenetic modifications of gut microbiota and their potential role in atherosclerosis. Front Pharmacol 16:1638240","journal-title":"Front Pharmacol"},{"key":"5249_CR69","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","volume":"74","author":"S Ha","year":"2024","unstructured":"Ha S, Wong VW, Zhang X, Yu J (2024) Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma. Gut 74:141\u2013152","journal-title":"Gut"},{"key":"5249_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110521","volume":"301","author":"JH Han","year":"2025","unstructured":"Han JH, Rey FE, Denu JM (2025) Gut microbiota-derived metabolite trimethylamine N-oxide alters the host epigenome through inhibition of S-adenosylhomocysteine hydrolase. J Biol Chem 301:110521","journal-title":"J Biol Chem"},{"key":"5249_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176356","volume":"21","author":"J He","year":"2020","unstructured":"He J, Zhang P, Shen L, Niu L, Tan Y, Chen L, Zhao Y, Bai L, Hao X, Li X, Zhang S, Zhu L (2020) Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. Int J Mol Sci 21:6356","journal-title":"Int J Mol Sci"},{"key":"5249_CR73","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41366-018-0093-2","volume":"43","author":"MF Hjorth","year":"2019","unstructured":"Hjorth MF, Bl\u00e6del T, Bendtsen LQ, Lorenzen JK, Holm JB, Kiilerich P, Roager HM, Kristiansen K, Larsen LH, Astrup A (2019) Prevotella-to-Bacteroides ratio predicts body weight and fat loss success on 24-week diets varying in macronutrient composition and dietary fiber: results from a post-hoc analysis. Int J Obes (Lond) 43:149\u2013157","journal-title":"Int J Obes (Lond)"},{"key":"5249_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.2004","volume":"7","author":"MJ Hossain","year":"2024","unstructured":"Hossain MJ, Al-Mamun M, Islam MR (2024) Diabetes mellitus, the fastest growing global public health concern: early detection should be focused. Health Sci Rep 7:e2004","journal-title":"Health Sci Rep"},{"key":"5249_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2026.115623","volume":"29","author":"S Hu","year":"2026","unstructured":"Hu S, He C, Sun K, Zhou H, Liu X, Wang H, Li S, Yu H, Xu K, Li W (2026) The gut-liver\/bile axis: gut microbiota and bacterial extracellular vesicles remodeling hepatobiliary pathogenesis. iScience 29:115623","journal-title":"iScience"},{"key":"5249_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041542","volume":"21","author":"S Hu","year":"2020","unstructured":"Hu S, Kuwabara R, de Haan BJ, Smink AM, de Vos P (2020) Acetate and butyrate improve \u03b2-cell metabolism and mitochondrial respiration under oxidative stress. Int J Mol Sci 21:1542","journal-title":"Int J Mol Sci"},{"key":"5249_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27125223","volume":"27","author":"S Hussain","year":"2026","unstructured":"Hussain S, Bekhite MM, Schulze PC (2026) Tryptophan metabolism in cardiometabolic diseases: focus on the kynurenine pathway. Int J Mol Sci 27:5223","journal-title":"Int J Mol Sci"},{"key":"5249_CR78","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fneur.2017.00265","volume":"8","author":"GA Jelinek","year":"2017","unstructured":"Jelinek GA (2017) Determining Causation from Observational Studies: A Challenge for Modern Neuroepidemiology. Front Neurol 8:265","journal-title":"Front Neurol"},{"key":"5249_CR79","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1631\/jzus.B1900073","volume":"20","author":"ET Jia","year":"2019","unstructured":"Jia ET, Liu ZY, Pan M, Lu JF, Ge QY (2019) Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases. J Zhejiang Univ Sci B 20:781\u2013792","journal-title":"J Zhejiang Univ Sci B"},{"key":"5249_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1661037","volume":"16","author":"H Jiang","year":"2025","unstructured":"Jiang H, Wang X, Zhou W, Huang Z, Zhang W (2025) Gut microbiota dysbiosis in diabetic nephropathy: mechanisms and therapeutic targeting via the gut-kidney axis. Front Endocrinol (Lausanne) 16:1661037","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5249_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/nu17091580","volume":"17","author":"C Jim\u00e9nez-Gonz\u00e1lez","year":"2025","unstructured":"Jim\u00e9nez-Gonz\u00e1lez C, Alonso-Pe\u00f1a M, Argos V\u00e9lez P, Crespo J, Iruzubieta P (2025) Unraveling MASLD: the role of gut microbiota, dietary modulation, and AI-driven lifestyle interventions. Nutrients 17:1580","journal-title":"Nutrients"},{"key":"5249_CR82","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202501579RR","volume":"39","author":"JY Jin","year":"2025","unstructured":"Jin JY, Yang XY, Feng R, Ye ML, Xu H, Wang JY, Hu JC, Zuo HT, Lu JY, Song JY, Zhao Y, Wang Y, Tong Q (2025a) Gut microbiota-derived metabolites orchestrate metabolic reprogramming in diabetic cardiomyopathy: mechanisms and therapeutic frontiers. FASEB J 39:e71004","journal-title":"FASEB J"},{"key":"5249_CR83","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13098-025-01802-9","volume":"17","author":"Z Jin","year":"2025","unstructured":"Jin Z, Zeng C, Yang Y, Zhong S, Zhou Z (2025b) Decoding survival in MASLD: the dominant role of metabolic factors. Diabetol Metab Syndr 17:226","journal-title":"Diabetol Metab Syndr"},{"key":"5249_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1677175","volume":"16","author":"M Jing","year":"2025","unstructured":"Jing M, Jiang Y (2025) Microbiome-mediated crosstalk between T2DM and MASLD: a translational review focused on function. Front Endocrinol (Lausanne) 16:1677175","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5249_CR85","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.eprac.2023.08.016","volume":"29","author":"S Joshi","year":"2023","unstructured":"Joshi S, Shamanna P, Dharmalingam M, Vadavi A, Keshavamurthy A, Shah L, Mechanick JI (2023) Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled Study. Endocr Pract 29:960\u2013970","journal-title":"Endocr Pract"},{"key":"5249_CR86","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"UJ Jung","year":"2014","unstructured":"Jung UJ, Choi MS (2014) Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 15:6184\u20136223","journal-title":"Int J Mol Sci"},{"key":"5249_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/nu17081305","volume":"17","author":"AE Kalkan","year":"2025","unstructured":"Kalkan AE, BinMowyna MN, Raposo A, Ahmad MF, Ahmed F, Otayf AY, Carrascosa C, Saraiva A, Karav S (2025) Beyond the gut: unveiling butyrate\u2019s global health impact through gut health and dysbiosis-related conditions: a narrative review. Nutrients 17:1305","journal-title":"Nutrients"},{"key":"5249_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105905","volume":"26","author":"GG Kang","year":"2022","unstructured":"Kang GG, Trevaskis NL, Murphy AJ, Febbraio MA (2022) Diet-induced gut dysbiosis and inflammation: key drivers of obesity-driven NASH. iScience 26:105905","journal-title":"iScience"},{"key":"5249_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1439176","volume":"15","author":"M Karimi","year":"2024","unstructured":"Karimi M, Shirsalimi N, Hashempour Z, Salehi Omran H, Sedighi E, Beigi F, Mortezazadeh M (2024) Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review. Front Immunol 15:1439176","journal-title":"Front Immunol"},{"key":"5249_CR90","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3390\/nu7042839","volume":"7","author":"M Kasubuchi","year":"2015","unstructured":"Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I (2015) Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7:2839\u20132849","journal-title":"Nutrients"},{"key":"5249_CR91","doi-asserted-by":"publisher","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","volume":"320","author":"T Kawai","year":"2021","unstructured":"Kawai T, Autieri MV, Scalia R (2021) Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol 320:C375\u2013C391","journal-title":"Am J Physiol Cell Physiol"},{"key":"5249_CR92","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim J, Koo BK, Knoblich JA (2020) Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol 21:571\u2013584","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5249_CR93","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cmet.2020.07.012","volume":"32","author":"A Koh","year":"2020","unstructured":"Koh A, Manner\u00e5s-Holm L, Yunn NO, Nilsson PM, Ryu SH, Molinaro A, Perkins R, Smith JG, B\u00e4ckhed F (2020) Microbial Imidazole Propionate Affects Responses to Metformin through p38\u03b3-Dependent Inhibitory AMPK Phosphorylation. Cell Metab 32:643\u2013653","journal-title":"Cell Metab"},{"key":"5249_CR94","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cell.2018.09.055","volume":"175","author":"A Koh","year":"2018","unstructured":"Koh A, Molinaro A, St\u00e5hlman M, Khan MT, Schmidt C, Manner\u00e5s-Holm L, Wu H, Carreras A, Jeong H, Olofsson LE, Bergh PO, Gerdes V, Hartstra A, de Brauw M, Perkins R, Nieuwdorp M, Bergstr\u00f6m G, B\u00e4ckhed F (2018) Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell 175:947\u2013961.e17","journal-title":"Cell"},{"key":"5249_CR95","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s13679-023-00527-y","volume":"12","author":"C Koliaki","year":"2023","unstructured":"Koliaki C, Dalamaga M, Liatis S (2023) Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten? Curr Obes Rep 12:514\u2013527","journal-title":"Curr Obes Rep"},{"key":"5249_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27042066","volume":"27","author":"N Kurhaluk","year":"2026","unstructured":"Kurhaluk N, Ko\u0142odziejska R, Mazur Z, Lukash O, Yakovenko O, Tkaczenko H (2026) Functional foods as modulators of epigenetic mechanisms affecting metabolic health in adolescence. Int J Mol Sci 27:2066","journal-title":"Int J Mol Sci"},{"key":"5249_CR97","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.atherosclerosis.2012.08.003","volume":"224","author":"JH Kwak","year":"2012","unstructured":"Kwak JH, Paik JK, Kim HI, Kim OY, Shin DY, Kim HJ, Lee JH, Lee JH (2012) Dietary treatment with rice containing resistant starch improves markers of endothelial function with reduction of postprandial blood glucose and oxidative stress in patients with prediabetes or newly diagnosed type 2 diabetes. Atherosclerosis 224:457\u2013464","journal-title":"Atherosclerosis"},{"key":"5249_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107672","volume":"214","author":"Y Lai","year":"2025","unstructured":"Lai Y, Zhu Y, Zhang X, Ding S, Wang F, Hao J, Wang Z, Shi C, Xu Y, Zheng L, Huang W (2025) Gut microbiota-derived metabolites: potential targets for cardiorenal syndrome. Pharmacol Res 214:107672","journal-title":"Pharmacol Res"},{"key":"5249_CR99","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/eva.13090","volume":"14","author":"A Landini","year":"2020","unstructured":"Landini A, Yu S, Gnecchi-Ruscone GA, Abondio P, Ojeda-Granados C, Sarno S, De Fanti S, Gentilini D, Di Blasio AM, Jin H, Nguyen TT, Romeo G, Prata C, Bortolini E, Luiselli D, Pettener D, Sazzini M (2020) Genomic adaptations to cereal-based diets contribute to mitigate metabolic risk in some human populations of East Asian ancestry. Evol Appl 14:297\u2013313","journal-title":"Evol Appl"},{"key":"5249_CR100","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41368-019-0053-2","volume":"11","author":"L Lawlor","year":"2019","unstructured":"Lawlor L, Yang XB (2019) Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering. Int J Oral Sci 11:20","journal-title":"Int J Oral Sci"},{"key":"5249_CR101","doi-asserted-by":"publisher","first-page":"1852596","DOI":"10.3389\/fcimb.2026.1852596","volume":"16","author":"H Li","year":"2026","unstructured":"Li H, Ye A, Song J, Yang Y, Li J (2026b) The gut microbiota-enteric nervous system axis: from bidirectional programming to precision therapeutics in digestive diseases. Front Cell Infect Microbiol 16:1852596","journal-title":"Front Cell Infect Microbiol"},{"key":"5249_CR102","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41591-025-04105-8","volume":"32","author":"J Li","year":"2026","unstructured":"Li J, Hu J, Yun H, Mei Z, Wang X, Luo K, Guasch-Ferr\u00e9 M, Han X, Truong B, Merino J, Jia C, Ruiz-Canela M, Rebholz CM, Moon EH, Alkis T, Liu G, Yao J, Zhang X, Porneala BC, Salas-Salvad\u00f3 J, Wang TJ, Dupuis J, Selvin E, Guo X, Bhupathiraju SN, Brody JA, Liu Y, Wood AC, North KE, Jung SY, Liu CT, Sotoodehnia N, Liu S, Tinker LF, Eliassen AH, Manson JE, Florez JC, Gerszten RE, Clish CB, Liang L, Lemaitre RN, Tucker KL, Rich SS, Rotter JI, Mart\u00ednez-Gonz\u00e1lez MA, Rexrode KM, Meigs JB, Boerwinkle E, Kaplan RC, Hu FB, Yu B, Qi Q (2026a) Circulating metabolites, genetics and lifestyle factors in relation to future risk of type 2 diabetes. Nat Med 32:660\u2013670","journal-title":"Nat Med"},{"key":"5249_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1209613","volume":"10","author":"S Li","year":"2023","unstructured":"Li S (2023) Modulation of immunity by tryptophan microbial metabolites. Front Nutr 10:1209613","journal-title":"Front Nutr"},{"key":"5249_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147943","volume":"25","author":"Y Liang","year":"2024","unstructured":"Liang Y, Kaushal D, Wilson RB (2024) Cellular senescence and extracellular vesicles in the pathogenesis and treatment of obesity-A narrative review. Int J Mol Sci 25:7943","journal-title":"Int J Mol Sci"},{"key":"5249_CR106","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.3748\/wjg.v27.i25.3837","volume":"27","author":"BN Liu","year":"2021","unstructured":"Liu BN, Liu XT, Liang ZH, Wang JH (2021) Gut microbiota in obesity. World J Gastroenterol 27:3837\u20133850","journal-title":"World J Gastroenterol"},{"key":"5249_CR107","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.14336\/AD.2022.0104","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C (2022) Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives. Aging Dis 13:1106\u20131126","journal-title":"Aging Dis"},{"key":"5249_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1614940","volume":"13","author":"S Liu","year":"2025","unstructured":"Liu S, Wang L, Zhu L, Zhao T, Han P, Yan F, Wang X, Li C, Wang Z, Yang BF (2025a) Mechanism and regulation of mitophagy in liver diseases: a review. Front Cell Dev Biol 13:1614940","journal-title":"Front Cell Dev Biol"},{"key":"5249_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083752","volume":"26","author":"W Liu","year":"2025","unstructured":"Liu W, Wang L, Ou J, Peng D, Zhang Y, Chen W, Wang Y (2025b) Gut microbiota metabolites and chronic diseases: interactions, mechanisms, and therapeutic strategies. Int J Mol Sci 26:3752","journal-title":"Int J Mol Sci"},{"key":"5249_CR110","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/nu17091463","volume":"17","author":"X Liu","year":"2025","unstructured":"Liu X, Xu M, Wang H, Zhu L (2025c) Role and Mechanism of Short-Chain Fatty Acids in Skeletal Muscle Homeostasis and Exercise Performance. Nutrients 17:1463","journal-title":"Nutrients"},{"key":"5249_CR111","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-026-01623-8","volume":"26","author":"S Longo","year":"2026","unstructured":"Longo S, Rinaldi TG, Fern\u00e1ndez-Real JM, Federici M (2026) Dysregulation of the gut-adipose tissue-liver axis: a possible mechanism behind the relationship between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes. Curr Diab Rep 26:10","journal-title":"Curr Diab Rep"},{"key":"5249_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2023.1267281","volume":"14","author":"M Luo","year":"2023","unstructured":"Luo M, Gong W, Zhang S, Xie L, Shi Y, Wu D, Shu X (2023) Discrepancies in resistant starch and starch physicochemical properties between rice mutants similar in high amylose content. Front Plant Sci 14:1267281","journal-title":"Front Plant Sci"},{"key":"5249_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-022-02704-w","volume":"22","author":"DO L\u00fctzh\u00f8ft","year":"2022","unstructured":"L\u00fctzh\u00f8ft DO, Sinioja T, Christoffersen B\u00d8, Jakobsen RR, Geng D, Ahmad HFB, Straarup EM, Pedersen KM, Kot W, Pedersen HD, Cirera S, Hy\u00f6tyl\u00e4inen T, Nielsen DS, Hansen AK (2022) Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH G\u00f6ttingen Minipig model. BMC Microbiol 22:287","journal-title":"BMC Microbiol"},{"key":"5249_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1639064","volume":"16","author":"J Ma","year":"2025","unstructured":"Ma J, Ma Y, Wan X, Li J, Zhang Y, Liu J, Gao Y (2025) Metabolic and genetic mechanisms of metabolic dysfunction-associated steatotic liver disease: an integrative perspective from molecular pathways to clinical challenges. Front Endocrinol (Lausanne) 16:1639064","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5249_CR115","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41392-024-01946-6","volume":"9","author":"Z Ma","year":"2024","unstructured":"Ma Z, Zuo T, Frey N, Rangrez AY (2024) A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation. Signal Transduct Target Ther 9:237","journal-title":"Signal Transduct Target Ther"},{"key":"5249_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/nu15020272","volume":"15","author":"KS May","year":"2023","unstructured":"May KS, den Hartigh LJ (2023) Gut microbial-derived short chain fatty acids: impact on adipose tissue physiology. Nutrients 15:272","journal-title":"Nutrients"},{"key":"5249_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1067647","volume":"9","author":"A Mayorga-Ramos","year":"2022","unstructured":"Mayorga-Ramos A, Barba-Ostria C, Simancas-Racines D, Guam\u00e1n LP (2022) Protective role of butyrate in obesity and diabetes: new insights. Front Nutr 9:1067647","journal-title":"Front Nutr"},{"key":"5249_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26072959","volume":"26","author":"JE Mej\u00eda-Guzm\u00e1n","year":"2025","unstructured":"Mej\u00eda-Guzm\u00e1n JE, Belmont-Hern\u00e1ndez RA, Ch\u00e1vez-Tapia NC, Uribe M, Nu\u00f1o-L\u00e1mbarri N (2025) Metabolic-dysfunction-associated steatotic liver disease: molecular mechanisms, clinical implications, and emerging therapeutic strategies. Int J Mol Sci 26:2959","journal-title":"Int J Mol Sci"},{"key":"5249_CR120","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/antiox15070897","volume":"15","author":"P Mester","year":"2026","unstructured":"Mester P, Steinmann SM, Mehler S, M\u00fcller M, G\u00fclow K (2026) Microbiota-Derived Metabolites in the Epigenetic Regulation of Redox Homeostasis. Antioxid (Basel) 15:897","journal-title":"Antioxid (Basel)"},{"key":"5249_CR121","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biomedicines8060154","volume":"8","author":"SP Mishra","year":"2020","unstructured":"Mishra SP, Karunakar P, Taraphder S, Yadav H (2020) Free Fatty Acid Receptors 2 and 3 as Microbial Metabolite Sensors to Shape Host Health: Pharmacophysiological View. Biomedicines 8:154","journal-title":"Biomedicines"},{"issue":"3","key":"5249_CR122","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/ijms26031094","volume":"26","author":"E M\u0142ynarska","year":"2025","unstructured":"M\u0142ynarska E, Czarnik W, Dzie\u017ca N, J\u0119draszak W, Majchrowicz G, Prusinowski F, Stabrawa M, Rysz J, Franczyk B (2025) Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications. Int J Mol Sci 26(3):1094","journal-title":"Int J Mol Sci"},{"key":"5249_CR123","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/nu17040639","volume":"17","author":"F Mohammadi","year":"2025","unstructured":"Mohammadi F, Rudkowska I (2025) Dietary Lipids, Gut Microbiota, and Their Metabolites: Insights from Recent Studies. Nutrients 17:639","journal-title":"Nutrients"},{"key":"5249_CR124","volume":"63","author":"S Moore","year":"2026","unstructured":"Moore S, Thakkar A, Notta S, Snipp J, McGuire C, Vedantam V, Jbara MH (2026) Obesity paradox in patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a nationwide retrospective observational study. Am Heart J Plus 63:100733","journal-title":"Am Heart J Plus"},{"key":"5249_CR125","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7:189\u2013200","journal-title":"Gut Microbes"},{"key":"5249_CR126","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/biom15040469","volume":"15","author":"E M\u00fcnte","year":"2025","unstructured":"M\u00fcnte E, Hartmann P (2025) The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases. Biomolecules 15:469","journal-title":"Biomolecules"},{"key":"5249_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094264","volume":"26","author":"B Muttiah","year":"2025","unstructured":"Muttiah B, Hanafiah A (2025) Gut microbiota and cardiovascular diseases: unraveling the role of dysbiosis and microbial metabolites. Int J Mol Sci 26:4264","journal-title":"Int J Mol Sci"},{"key":"5249_CR128","doi-asserted-by":"crossref","unstructured":"Mylavarapu M, Tiwari A, Kaur H, Vempati R, Kumar H, Kodali LSM, Khan KG, Dadana S, Garcia I, Cabrera FEP, Singh A, Kyasa SL, Purewal VS (2026) The gut-heart axis: a comprehensive review of microbiota\u2019s role in cardiovascular health and disease and emerging therapeutic strategies. Cardiol Res Pract","DOI":"10.1155\/crp\/9920016"},{"key":"5249_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713090","volume":"24","author":"MN Nicese","year":"2023","unstructured":"Nicese MN, Bijkerk R, Van Zonneveld AJ, Van den Berg BM, Rotmans JI (2023) Sodium butyrate as key regulator of mitochondrial function and barrier integrity of human glomerular endothelial cells. Int J Mol Sci 24:13090","journal-title":"Int J Mol Sci"},{"key":"5249_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","volume":"13","author":"A Nogal","year":"2021","unstructured":"Nogal A, Valdes AM, Menni C (2021) The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes 13:1\u201324","journal-title":"Gut Microbes"},{"key":"5249_CR131","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.yjmcc.2010.11.005","volume":"51","author":"N Noor","year":"2011","unstructured":"Noor N, Patel CB, Rockman HA (2011) \u0392-arrestin: a signaling molecule and potential therapeutic target for heart failure. J Mol Cell Cardiol 51:534\u2013541","journal-title":"J Mol Cell Cardiol"},{"key":"5249_CR132","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s42255-024-01191-9","volume":"7","author":"M Nshanian","year":"2025","unstructured":"Nshanian M, Gruber JJ, Geller BS, Chleilat F, Lancaster SM, White SM, Alexandrova L, Camarillo JM, Kelleher NL, Zhao Y, Snyder MP (2025) Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression. Nat Metab 7:196\u2013211","journal-title":"Nat Metab"},{"key":"5249_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101982","volume":"6","author":"KJ O\u2019Riordan","year":"2025","unstructured":"O\u2019Riordan KJ, Moloney GM, Keane L, Clarke G, Cryan JF (2025) The gut microbiota-immune-brain axis: therapeutic implications. Cell Rep Med 6:101982","journal-title":"Cell Rep Med"},{"key":"5249_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.715877","volume":"12","author":"C Oliveira de Souza","year":"2021","unstructured":"Oliveira de Souza C, Sun X, Oh D (2021) Metabolic functions of G protein-coupled receptors and \u03b2-arrestin-mediated signaling pathways in the pathophysiology of type 2 diabetes and obesity. Front Endocrinol (Lausanne) 12:715877","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5249_CR135","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2026.2672794","volume":"18","author":"B Oliver","year":"2026","unstructured":"Oliver B, Sun M, Lee YS, Cho S, Zhu T, Durgan D, Sweeney G (2026) Gut-derived bacterial extracellular vesicles: the microbial dark matter contributing to host inflammation and cardiometabolic disease. Gut Microbes 18:2672794","journal-title":"Gut Microbes"},{"key":"5249_CR136","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s40795-025-01088-0","volume":"11","author":"A Panda","year":"2025","unstructured":"Panda A, Parida J, Jena S, Behera SS, Pradhan A, Patra PK, Pati S, Kaur H, Acharya SK (2025) Prevalence and associated risk factors of overweight and obesity among adolescent population of India: a scoping review. BMC Nutr 11:110","journal-title":"BMC Nutr"},{"key":"5249_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45125-1","volume":"15","author":"P Papareddy","year":"2024","unstructured":"Papareddy P, Tapken I, Kroh K, Varma Bhongir RK, Rahman M, Baumgarten M, Cim EI, Gy\u00f6rffy L, Smeds E, Neumann A, Veerla S, Olinder J, Thorlacus H, Ryden C, Bartakova E, Holub M, Herwald H (2024) The role of extracellular vesicle fusion with target cells in triggering systemic inflammation. Nat Commun 15:1150","journal-title":"Nat Commun"},{"issue":"2","key":"5249_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9020216","volume":"9","author":"S Patergnani","year":"2021","unstructured":"Patergnani S, Bouhamida E, Leo S, Pinton P, Rimessi A (2021) Mitochondrial oxidative stress and \u201cmito-inflammation\u201d: actors in the diseases. Biomedicines 9(2):216","journal-title":"Biomedicines"},{"key":"5249_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26041773","volume":"26","author":"E Pe\u00f1a-Dur\u00e1n","year":"2025","unstructured":"Pe\u00f1a-Dur\u00e1n E, Garc\u00eda-Galindo JJ, L\u00f3pez-Murillo LD, Huerta-Huerta A, Balleza-Alejandri LR, Beltr\u00e1n-Ram\u00edrez A, Anaya-Ambriz EJ, Su\u00e1rez-Rico DO (2025) Microbiota and inflammatory markers: a review of their interplay, clinical implications, and metabolic disorders. Int J Mol Sci 26:1773","journal-title":"Int J Mol Sci"},{"key":"5249_CR140","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/nu18020290","volume":"18","author":"J Plaza-Diaz","year":"2026","unstructured":"Plaza-Diaz J, Herrera-Quintana L, Olivares-Arancibia J, V\u00e1zquez-Lorente H (2026) Personalized Nutrition Through the Gut Microbiome in Metabolic Syndrome and Related Comorbidities. Nutrients 18:290","journal-title":"Nutrients"},{"key":"5249_CR141","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13366","volume":"23","author":"BM Popkin","year":"2022","unstructured":"Popkin BM, Ng SW (2022) The nutrition transition to a stage of high obesity and noncommunicable disease prevalence dominated by ultra-processed foods is not inevitable. Obes Rev 23:e13366","journal-title":"Obes Rev"},{"key":"5249_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031105","volume":"23","author":"P Portincasa","year":"2022","unstructured":"Portincasa P, Bonfrate L, Vacca M, De Angelis M, Farella I, Lanza E, Khalil M, Wang DQ, Sperandio M, Di Ciaula A (2022) Gut microbiota and short chain fatty acids: implications in glucose homeostasis. Int J Mol Sci 23:1105","journal-title":"Int J Mol Sci"},{"key":"5249_CR143","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/j.2040-4603.2018.tb00038.x","volume":"8","author":"M Priyadarshini","year":"2018","unstructured":"Priyadarshini M, Kotlo KU, Dudeja PK, Layden BT (2018) Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology. Compr Physiol 8:1091\u20131115","journal-title":"Compr Physiol"},{"key":"5249_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.mocell.2025.100216","volume":"48","author":"LN Qin","year":"2025","unstructured":"Qin LN, Yu YF, Ma L, Yu R (2025) Intestinal bacteria-derived extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics. Mol Cells 48:100216","journal-title":"Mol Cells"},{"key":"5249_CR145","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cellsig.2017.01.024","volume":"41","author":"S Rajagopal","year":"2017","unstructured":"Rajagopal S, Shenoy SK (2017) GPCR desensitization: Acute and prolonged phases. Cell Signal 41:9\u201316","journal-title":"Cell Signal"},{"key":"5249_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.793414","volume":"8","author":"AA Rashed","year":"2022","unstructured":"Rashed AA, Saparuddin F, Rathi DG, Nasir NNM, Lokman EF (2022) Effects of resistant starch interventions on metabolic biomarkers in pre-diabetes and diabetes adults. Front Nutr 8:793414","journal-title":"Front Nutr"},{"key":"5249_CR147","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.2147\/DMSO.S319895","volume":"14","author":"J Reed","year":"2026","unstructured":"Reed J, Bain S, Kanamarlapudi V (2026) A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives. Diabetes Metab Syndr Obes 14:3567\u20133602","journal-title":"Diabetes Metab Syndr Obes"},{"key":"5249_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1769792","volume":"17","author":"L Ren","year":"2026","unstructured":"Ren L, Li M, Wu L, Lin Z, Chen A (2026) Microbial transformation of secondary bile acids: roles in gut ecology and autoimmune diseases. Front Immunol 17:1769792","journal-title":"Front Immunol"},{"key":"5249_CR149","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ymeth.2023.12.007","volume":"222","author":"J Roach","year":"2024","unstructured":"Roach J, Mital R, Haffner JJ, Colwell N, Coats R, Palacios HM, Liu Z, Godinho JLP, Ness M, Peramuna T, McCall LI (2024) Microbiome metabolite quantification methods enabling insights into human health and disease. Methods 222:81\u201399","journal-title":"Methods"},{"key":"5249_CR150","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i8.108182","volume":"17","author":"S Rodriguez","year":"2025","unstructured":"Rodriguez S, Dahlem MLF, Rossoni C, Marroni NP, Marroni CA, Fernandes SA (2025) Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 17:108182","journal-title":"World J Hepatol"},{"key":"5249_CR151","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/dom.70659","volume":"Suppl 2","author":"M Romanos","year":"2026","unstructured":"Romanos M, Garcia Cordova JM, Villamarin J, Pazmino Zurita JD, Acosta A (2026) Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD): a literature review on pathophysiology and treatment. Diabetes Obes Metab Suppl 2:19\u201330","journal-title":"Diabetes Obes Metab"},{"key":"5249_CR152","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1053\/j.gastro.2025.02.035","volume":"169","author":"T Rozera","year":"2025","unstructured":"Rozera T, Pasolli E, Segata N, Ianiro G (2025) Machine Learning and Artificial Intelligence in the Multi-Omics Approach to Gut Microbiota. Gastroenterology 169:487\u2013501","journal-title":"Gastroenterology"},{"key":"5249_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1161521","volume":"14","author":"R Ruze","year":"2023","unstructured":"Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R, Yin X, Xu Q (2023) Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front Endocrinol (Lausanne) 14:1161521","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5249_CR154","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262411897","volume":"26","author":"P Rzeczycki","year":"2025","unstructured":"Rzeczycki P, P\u0119ciak O, Plust M, Dro\u017adzik M (2025) Gut microbiota in the regulation of intestinal drug transporters: molecular mechanisms and pharmacokinetic implications. Int J Mol Sci 26:11897","journal-title":"Int J Mol Sci"},{"key":"5249_CR155","doi-asserted-by":"publisher","first-page":"e83059","DOI":"10.2196\/83059","volume":"11","author":"F Sarani Rad","year":"2026","unstructured":"Sarani Rad F, Jafarpour M, Bitaraf E, Khaleghdadi K, Li J (2026) Digital twin applications in diabetes management: scoping review. JMIR Diabetes 11:e83059","journal-title":"JMIR Diabetes"},{"key":"5249_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571731","volume":"11","author":"TPM Scheithauer","year":"2020","unstructured":"Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H (2020) Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol 11:571731","journal-title":"Front Immunol"},{"key":"5249_CR157","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186423","volume":"135","author":"B Schnabl","year":"2025","unstructured":"Schnabl B, Damman CJ, Carr RM (2025) Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations. J Clin Invest 135:e186423","journal-title":"J Clin Invest"},{"key":"5249_CR158","doi-asserted-by":"publisher","first-page":"25478","DOI":"10.1038\/s41598-024-76584-7","volume":"14","author":"P Shamanna","year":"2024","unstructured":"Shamanna P, Erukulapati RS, Shukla A, Shah L, Willis B, Thajudeen M, Kovil R, Baxi R, Wali M, Damodharan S, Joshi S (2024a) One-year outcomes of a digital twin intervention for type 2 diabetes: a retrospective real-world study. Sci Rep 14:25478","journal-title":"Sci Rep"},{"key":"5249_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1485464","volume":"15","author":"P Shamanna","year":"2024","unstructured":"Shamanna P, Joshi S, Thajudeen M, Shah L, Poon T, Mohamed M, Mohammed J (2024b) Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control. Front Endocrinol (Lausanne) 15:1485464","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5249_CR160","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.125.25962","volume":"83","author":"H Shi","year":"2026","unstructured":"Shi H, Shi F, Wagle R, Gonzalez-Gonzalez MA, Mell B, Oliver B, Zhu T, Joe B, Durgan DJ (2026) Bacterial extracellular vesicles mediate microbiota-host communication to regulate blood pressure in male rats. Hypertension 83:e25962","journal-title":"Hypertension"},{"key":"5249_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102287","volume":"11","author":"Z Shi","year":"2019","unstructured":"Shi Z (2019) Gut microbiota: an important link between western diet and chronic diseases. Nutrients 11:2287","journal-title":"Nutrients"},{"key":"5249_CR162","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2026.2665890","volume":"18","author":"J Shou","year":"2026","unstructured":"Shou J, Fu T (2026) The gut microbiome-bile acid-FXR interplay: a pivotal axis in metabolic and gastrointestinal diseases. Gut Microbes 18:2665890","journal-title":"Gut Microbes"},{"key":"5249_CR163","volume":"17","author":"S Shruthi","year":"2025","unstructured":"Shruthi S, Lakshmi G, T S M, Washington JK (2025) Prevalence and predictors of metabolic syndrome in women with polycystic ovarian syndrome: a cross-sectional study. Cureus 17:e98869","journal-title":"Cureus"},{"key":"5249_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179339","volume":"25","author":"AF Sobral","year":"2024","unstructured":"Sobral AF, Cunha A, Silva V, Gil-Martins E, Silva R, Barbosa DJ (2024) Unveiling the therapeutic potential of folate-dependent one-carbon metabolism in cancer and neurodegeneration. Int J Mol Sci 25:9339","journal-title":"Int J Mol Sci"},{"key":"5249_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1607899","volume":"12","author":"G Song","year":"2025","unstructured":"Song G, Xie Y, Yi L, Cheng W, Jia H, Shi W, Liu Q, Fang L, Xue S, Liu D, Zhu J, Zhao S (2025) Bile acids affect intestinal barrier function through FXR and TGR5. Front Med (Lausanne) 12:1607899","journal-title":"Front Med (Lausanne)"},{"key":"5249_CR167","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/s12276-026-01776-2","volume":"58","author":"H Song","year":"2026","unstructured":"Song H, Yun C, Choi Y, Jeong W, Kim Y, Kim J, Lee JY, Ryu D, Park SW, Oh CM (2026) Urolithin A activates mitophagy via the AMPK-mTOR axis and modulates the gut-ceramide axis to ameliorate cardiac remodeling in HFpEF. Exp Mol Med 58:2325\u20132338","journal-title":"Exp Mol Med"},{"key":"5249_CR168","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186420","volume":"135","author":"GR Steinberg","year":"2025","unstructured":"Steinberg GR, Carpentier AC, Wang D (2025) MASH: the nexus of metabolism, inflammation, and fibrosis. J Clin Invest 135:e186420","journal-title":"J Clin Invest"},{"key":"5249_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1264889","volume":"14","author":"A Stierschneider","year":"2023","unstructured":"Stierschneider A, Wiesner C (2023) Shedding light on the molecular and regulatory mechanisms of TLR4 signaling in endothelial cells under physiological and inflamed conditions. Front Immunol 14:1264889","journal-title":"Front Immunol"},{"key":"5249_CR170","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41575-025-01058-8","volume":"22","author":"Z Sun","year":"2025","unstructured":"Sun Z, Zheng Y (2025) Metabolic diseases in the East Asian populations. Nat Rev Gastroenterol Hepatol 22:500\u2013516","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5249_CR171","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2026-002294","volume":"13","author":"K Tachi","year":"2026","unstructured":"Tachi K, Agyei-Nkansah A, Atiase Y, Forkuo B, Agyen-Frimpong VA (2026) Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications. BMJ Open Gastroenterol 13:e002294","journal-title":"BMJ Open Gastroenterol"},{"key":"5249_CR172","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0346934","volume":"21","author":"XR Teh","year":"2026","unstructured":"Teh XR, Ang SH, Lee PJ, Mohd Ropidi MI, Abdul Samad A, Sivasampu S, Wan KS (2026) Primary health care interventions targeting diabetes, hypertension or dyslipidemia in Malaysia: a scoping review. PLoS One 21:e0346934","journal-title":"PLoS One"},{"key":"5249_CR173","doi-asserted-by":"publisher","first-page":"83","DOI":"10.12938\/bmfh.2021-085","volume":"41","author":"P Therdtatha","year":"2022","unstructured":"Therdtatha P, Shinoda A, Nakayama J (2022) Crisis of the Asian gut: associations among diet, microbiota, and metabolic diseases. Biosci Microbiota Food Health 41:83\u201393","journal-title":"Biosci Microbiota Food Health"},{"key":"5249_CR174","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9050897","volume":"9","author":"P Therdtatha","year":"2021","unstructured":"Therdtatha P, Song Y, Tanaka M, Mariyatun M, Almunifah M, Manurung NEP, Indriarsih S, Lu Y, Nagata K, Fukami K, Ikeda T, Lee YK, Rahayu ES, Nakayama J (2021) Gut microbiome of Indonesian adults associated with obesity and type 2 diabetes: a cross-sectional study in an Asian city, Yogyakarta. Microorganisms 9:897","journal-title":"Microorganisms"},{"key":"5249_CR175","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41574-022-00794-0","volume":"19","author":"M Van Hul","year":"2023","unstructured":"Van Hul M, Cani PD (2023) The gut microbiota in obesity and weight management: microbes as friends or foe? Nat Rev Endocrinol 19:258\u2013271","journal-title":"Nat Rev Endocrinol"},{"key":"5249_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2026.100610","volume":"17","author":"CA van Kalkeren","year":"2026","unstructured":"van Kalkeren CA, Adam TC, Blaak EE (2026) Gut microbiome-associated effects of plant-based diets on glucose homeostasis, body composition, and cognitive function: a scoping review. Adv Nutr 17:100610","journal-title":"Adv Nutr"},{"key":"5249_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2026.108194","volume":"227","author":"C Wang","year":"2026","unstructured":"Wang C, Zhang W, Shu Y, Song L, Wan Y, Zhang H, Bo L, Guo Y (2026a) Metabolic control of immunity and inflammation: mitochondrial dynamics, pharmacological targets, and therapeutic opportunities. Pharmacol Res 227:108194","journal-title":"Pharmacol Res"},{"key":"5249_CR180","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.aninu.2023.07.001","volume":"15","author":"GY Wang","year":"2023","unstructured":"Wang GY, Qin SL, Zheng YN, Geng HJ, Chen L, Yao JH, Deng L (2023) Propionate promotes gluconeogenesis by regulating mechanistic target of rapamycin (mTOR) pathway in calf hepatocytes. Anim Nutr 15:88\u201398","journal-title":"Anim Nutr"},{"key":"5249_CR181","doi-asserted-by":"publisher","first-page":"2644681","DOI":"10.1080\/19490976.2026.2644681","volume":"18","author":"Y Wang","year":"2026","unstructured":"Wang Y, Huang B, Wei X, Guan Y, Li L, Zheng Y, Sun W (2026b) Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host. Gut Microbes 18:2644681","journal-title":"Gut Microbes"},{"key":"5249_CR182","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1574887","volume":"16","author":"L Wen","year":"2025","unstructured":"Wen L, Yang K, Wang J, Zhou H, Ding W (2025) Gut microbiota-mitochondrial crosstalk in obesity: novel mechanistic insights and therapeutic strategies with traditional Chinese medicine. Front Pharmacol 16:1574887","journal-title":"Front Pharmacol"},{"key":"5249_CR183","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM (2020) Metabolic Inflammation and Insulin Resistance in Obesity. Circ Res 126:1549\u20131564","journal-title":"Circ Res"},{"key":"5249_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1114424","volume":"14","author":"J Wu","year":"2023","unstructured":"Wu J, Yang K, Fan H, Wei M, Xiong Q (2023) Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus. Front Endocrinol (Lausanne) 14:1114424","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5249_CR185","doi-asserted-by":"publisher","DOI":"10.31083\/RCM42406","volume":"26","author":"L Wu","year":"2025","unstructured":"Wu L, Xu J, Wu C, Wang M, Chen T, Ji C, Mao W (2025) Advances in molecular mechanisms and precision interventions of cardiovascular injuries related to glucose and lipid metabolism disorders. Rev Cardiovasc Med 26:42406","journal-title":"Rev Cardiovasc Med"},{"key":"5249_CR186","doi-asserted-by":"publisher","DOI":"10.3390\/nu17111876","volume":"17","author":"Z Xia","year":"2025","unstructured":"Xia Z, Li Y, Yin J, Gong Z, Sun J, Shen S, Yang Y, Liu T, Wang L, Huo J (2025) Integrating metabolomics and gut microbiota to identify key biomarkers and regulatory pathways underlying metabolic heterogeneity in childhood obesity. Nutrients 17:1876","journal-title":"Nutrients"},{"key":"5249_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116791","volume":"233","author":"C Xie","year":"2025","unstructured":"Xie C, Qi C, Zhang J, Wang W, Meng X, Aikepaer A, Lin Y, Su C, Liu Y, Feng X, Gao H (2025) When short-chain fatty acids meet type 2 diabetes mellitus: revealing mechanisms, envisioning therapies. Biochem Pharmacol 233:116791","journal-title":"Biochem Pharmacol"},{"key":"5249_CR188","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2026.1740680","volume":"17","author":"J Xie","year":"2026","unstructured":"Xie J, Zhang J, Zhang L, Chen X (2026) Exercise prescription for mood and cognition: targeting the microbiota-gut-brain axis through short-chain fatty acids. Front Microbiol 17:1740680","journal-title":"Front Microbiol"},{"key":"5249_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106174","volume":"80","author":"Y Xinqiang","year":"2020","unstructured":"Xinqiang Y, Quan C, Yuanyuan J, Hanmei X (2020) Protective effect of MOTS-c on acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol 80:106174","journal-title":"Int Immunopharmacol"},{"key":"5249_CR190","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1568211","volume":"12","author":"B Xu","year":"2025","unstructured":"Xu B, Li H, Pi Y, Li K (2025a) Global, regional and national burden of metabolic dysfunction-associated steatotic liver disease in adolescents and adults aged 15\u201349 years from 1990 to 2021: results from the 2021 Global Burden of Disease study. Front Med (Lausanne) 12:1568211","journal-title":"Front Med (Lausanne)"},{"key":"5249_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1454210","volume":"15","author":"Q Xu","year":"2024","unstructured":"Xu Q, Wang W, Li Y, Liu Y, Liu Y (2024) Imidazole propionate in type 2 diabetes mellitus and cardiovascular diseases: a mini review. Front Immunol 15:1454210","journal-title":"Front Immunol"},{"key":"5249_CR192","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15010064","volume":"15","author":"X Xu","year":"2025","unstructured":"Xu X, Jia L, Qiao B, Gong Y, Gao S, Wang Y, Du J (2025b) Changes in phenylacetylglutamine levels provide add-on value in risk stratification of hypertensive patients: a longitudinal cohort study. Metabolites 15:64","journal-title":"Metabolites"},{"key":"5249_CR193","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/cells15020095","volume":"15","author":"Y Xu","year":"2026","unstructured":"Xu Y, Jian X, Shi L, Shock LS, Chen L, Chow LT, Wang H (2026) Mitochondria and Epigenetic Regulation: Bidirectional Crosstalk and Emerging Mitochondria-Targeted Degron Tools. Cells 15:95","journal-title":"Cells"},{"key":"5249_CR194","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1017147","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang Z, Fu H, Su H, Cai X, Wang Y, Hong Y, Hu J, Xie Z, Wang X (2022) Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome. Front Microbiol 13:1017147","journal-title":"Front Microbiol"},{"key":"5249_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.903526","volume":"13","author":"X Ye","year":"2022","unstructured":"Ye X, Li H, Anjum K, Zhong X, Miao S, Zheng G, Liu W, Li L (2022) Dual role of indoles derived from intestinal microbiota on human health. Front Immunol 13:903526","journal-title":"Front Immunol"},{"key":"5249_CR198","doi-asserted-by":"publisher","DOI":"10.1177\/20420188251362011","volume":"16","author":"X Yu","year":"2025","unstructured":"Yu X, Kan C, Zhang K, Zhang X, Ren J, Chen J, Wang Y, Zhang Y, Zhang G, Sun X (2025a) Global epidemiology and burden of type 2 diabetes in adults aged 55 and older: insights from 1990 to 2021. Ther Adv Endocrinol Metab 16:20420188251362011","journal-title":"Ther Adv Endocrinol Metab"},{"key":"5249_CR199","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/metabo15060397","volume":"15","author":"Y Yu","year":"2025","unstructured":"Yu Y, Ding Y, Wang S, Jiang L (2025b) Gut Microbiota Dysbiosis and Its Impact on Type 2 Diabetes: From Pathogenesis to Therapeutic Strategies. Metabolites 15:397","journal-title":"Metabolites"},{"key":"5249_CR200","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","volume":"21","author":"D Zhang","year":"2023","unstructured":"Zhang D, Jian YP, Zhang YN, Li Y, Gu LT, Sun HH, Liu MD, Zhou HL, Wang YS, Xu ZX (2023) Short-chain fatty acids in diseases. Cell Commun Signal 21:212","journal-title":"Cell Commun Signal"},{"key":"5249_CR201","doi-asserted-by":"publisher","first-page":"766590","DOI":"10.3389\/fcimb.2021.766590","volume":"11","author":"K Zhang","year":"2021","unstructured":"Zhang K, Huang Q, Deng S, Yang Y, Li J, Wang S (2021a) Mechanisms of TLR4-Mediated Autophagy and Nitroxidative Stress. Front Cell Infect Microbiol 11:766590","journal-title":"Front Cell Infect Microbiol"},{"key":"5249_CR202","doi-asserted-by":"crossref","unstructured":"Zhang L, Chu J, Hao W, Zhang J, Li H, Yang C, Yang J, Chen X, Wang H (2021b) Gut microbiota and type 2 diabetes mellitus: association, mechanism, and translational applications. Mediators Inflamm","DOI":"10.1155\/2021\/5110276"},{"key":"5249_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111852","volume":"131","author":"L Zhang","year":"2024","unstructured":"Zhang L, Ma Z, Zhang X, Wang J, Tian W, Ren Y, Liu Y, Wang T, Li Y, Liu Y, Shen W, Li T, Liu J, Ma J, Zhang X, Yang S, Wang H (2024a) Butyrate alleviates alcoholic liver disease-associated inflammation through macrophage regulation and polarization via the HDAC1\/miR-155 axis. Int Immunopharmacol 131:111852","journal-title":"Int Immunopharmacol"},{"key":"5249_CR204","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1719902","volume":"17","author":"L Zhang","year":"2026","unstructured":"Zhang L, Xu C, Su T, Xiao T, Yi X, Feng Y, Wang J, Zhao S (2026) Single-nucleus and spatial transcriptomics reveal intestinal cellular heterogeneity, differentiation, and cell communication mechanisms in SAP-induced intestinal injury. Front Immunol 17:1719902","journal-title":"Front Immunol"},{"key":"5249_CR205","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000484","volume":"8","author":"R Zhang","year":"2024","unstructured":"Zhang R, Yan Z, Zhong H, Luo R, Liu W, Xiong S, Liu Q, Liu M (2024b) Gut microbial metabolites in MASLD: implications of mitochondrial dysfunction in the pathogenesis and treatment. Hepatol Commun 8:e0484","journal-title":"Hepatol Commun"},{"key":"5249_CR206","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1652683","volume":"13","author":"T Zhang","year":"2025","unstructured":"Zhang T, Li Z, Xu Y, Xu C, Wang H, Rui T (2025) Regulation of mitochondrial dynamics in cardiomyocytes: implications for cardiac health and disease. Front Cell Dev Biol 13:1652683","journal-title":"Front Cell Dev Biol"},{"key":"5249_CR207","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12872-025-04910-6","volume":"25","author":"S Zhao","year":"2025","unstructured":"Zhao S, Liu H, Liu A (2025) Associations of cardiovascular-kidney-metabolic conditions with all-cause and cardiovascular mortality among US adults: a population-based cohort study. BMC Cardiovasc Disord 25:443","journal-title":"BMC Cardiovasc Disord"},{"key":"5249_CR209","doi-asserted-by":"publisher","first-page":"4","DOI":"10.32607\/actanaturae.11151","volume":"12","author":"ES Zhgun","year":"2020","unstructured":"Zhgun ES, Ilina EN (2020) Fecal Metabolites As Non-Invasive Biomarkers of Gut Diseases. Acta Naturae 12:4\u201314","journal-title":"Acta Naturae"},{"key":"5249_CR210","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1620829","volume":"15","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Sun Y, Yin P, Zuo S, Li H, Cao K (2025) Bacterial extracellular vesicles: emerging mediators of gut-liver axis crosstalk in hepatic diseases. Front Cell Infect Microbiol 15:1620829","journal-title":"Front Cell Infect Microbiol"},{"key":"5249_CR211","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s13668-020-00307-3","volume":"9","author":"T Zhu","year":"2020","unstructured":"Zhu T, Goodarzi MO (2020) Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes. Curr Nutr Rep 9:83\u201393","journal-title":"Curr Nutr Rep"},{"key":"5249_CR212","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1186\/s12889-025-22702-7","volume":"25","author":"XY Zhu","year":"2025","unstructured":"Zhu XY, Shi MQ, Jiang ZM, Xiao-Li, Tian JW, Su FF (2025) Global, regional, and national burden of cardiovascular diseases attributable to metabolic risks across all age groups from 1990 to 2021: an analysis of the 2021 global burden of disease study data. BMC Public Health 25:1704","journal-title":"BMC Public Health"}],"updated-by":[{"DOI":"10.1007\/s11274-026-05263-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000}}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-026-05249-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-026-05249-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-026-05249-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:02:29Z","timestamp":1791529349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-026-05249-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":199,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5249"],"URL":"https:\/\/doi.org\/10.1007\/s11274-026-05249-6","relation":{},"ISSN":["1573-0972"],"issn-type":[{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to change in the author group.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11274-026-05263-8","URL":"https:\/\/doi.org\/10.1007\/s11274-026-05263-8","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"514"}}